OUTSIDE ACADEMIA PROFESSIONAL DEVELOPMENT EVENT.
EXPLORE YOUR CAREER OPTIONS AFTER POSTDOCOTRAL TRAINING 2017
May 31st


Are you wondering what to do after postdoctoral training? Are you considering changing career path? Are you wondering what skills are required to make this change? If you are, join our round table discussions with professionals in non-academic and non-research industries on May 31st!

KIPA and Karolinska Institutet Career Service are hosting a ‘Careers Outside Academia’ event aimed at helping postdocs prepare themselves for the next step in their careers.

We will have informal round table discussions of a small group of people, so it will be interactive and you will get the chance to ask all the questions you want!
At the round tables, you will find professionals in non-academic and non-research industries with previous research experience.
This event is an opportunity to identify potential future career paths and to determine what skills are required to secure that dream job.


Where?
Medicinska Föreningen Aula
Nobels Väg 10, Solna Campus

When?
17:30 on Wednesday 31st May.

How does it work?
Each attendee will have the opportunity to take part in two roundtable discussion sessions.
Don’t worry, if you have more questions or would like to talk to more speakers, the event will be
followed by a networking session with refreshments.

Registration opens on May 4th and closes on May 24th
Click here to register!

We are delighted to have the following Speakers at our round tables:

Align with Academia:
Björn Kull
, KI Grant Office, Head of Unit.
Amelie Plymoth, KI Medical Epidemiology and Biostatistics, Lecturer/Researcher.
Anas Kamleh, Thermo Fisher Scientific, Application and Training Specialist.

Away from the bench:
Sara Borniquel
, Rekryteringsspecialisten, Recruitment Consultant.
Nils Ekstrom, QuintilesIMS health, Data Analyst/Consultant.
Ana Catarina Araújo Silva, Calmark Sweden, Product Developer.
Anna Omelyanenko, Boston Consulting Group, Associate.
Barbara Albiger, European Centre for Disease Prevention and Control, Expert Microbiologist.
Ann Lundström, Naturvetarna, Career Advisor.

Bridging academia
Magnus Nord
, AstraZeneca, Director and Head of the Translational Science Centre.
Bernadette Schriener, Olerup SSP, Molecular Biologist.
Per Lundin, Evox Therapeutics, Chief Operating Officer.
Samir El Andaloussi, Evox Therapeutics, Group Leader.
Anders Mälarstig, Pfizer, Director.
Hovsep Mahdessiam, Bayer, Medical Science Laison.
Mira Ernkvist, Roche, Country Medical Lead.

Speakers' bios

Björn Kull, PhD
KI Grants Office
Head of Unit


"Over the past 15 years, I have work in, and in support of, innovation driven research and its financing. I graduated 1994 in Molecular Pharmacology at the University of Lund followed by postgraduate training at Karolinska Institutet where I received a doctorate degree in Neuropharmacology. After two years post-doc supported by the Swedish Brain foundation, I joined Biovitrum AB where I worked mainly with target validation and assay development. In 2005 I was part of starting up a small pharmaceutical company integrated in Karolinska Institutet innovation system. My main responsibilities at Actar AB included in- licensing evaluation and due diligence of research projects, management and research strategy. Other major duties included project evaluation and planning, infrastructure build-up and recruitment. In 2012 I joined the Swedish life science organization, SwedenBIO, managing a support office with aim to help Swedish Life Science companies to obtain funding from the EU's Framework Program (FP7). In my current position as head of Grants Office at Karolinska Institutet I am leading a unit with highly qualified staff that represents a strong mix of capabilities within scientific research and administration, scientific writing, communication and knowledge within the domains of the European Union and other international and national funding bodies.
I have over the years gained a deep knowledge in the various national and European funding programs and I am dedicated to a career in the borderland of academia and life science industry."

Amelie Plymoth, PhD
KI Medical Epidemiology and Biostatistics
Lecturer/Researcher

Anas Kamleh, PhD
Thermo Fisher Scientific
Application and Training Specialist

Sara Borniquel, PhD
Rekryteringsspecialisten
Recruitment Consultant


Sara completed a PhD in Biochemistry and Molecular Biology at the National Centre of Cardiovascular Research in Madrid, Spain in 2007. From 2008 – 2010 Sara worked as a postdoc at the Department of Physiology & Pharmacology at Karolinska Institute before becoming project leader of a study linking Mediterranean diet and chronic inflammatory diseases until 2014. After undertaking a couple of internship through the KI Career Service and taking several courses in business and marketing, Sara moved to Karo Bio as a Project Manager Assistant. In this position she was responsible for assisting researchers to find and procure funding.
Since 2016 Sara has worked at Rerkyteringsspecialisten AB, a Swedish recruitment firm. In addition she started her own consulting firm that assists research and development companies find funds and manage projects. Between March-Sept 2016 SARA was a Scientific Specialist at GAEU Consulting AB in which she established and developed relationships with key players in the Swedish Life Science-sector.

Nils Ekstrom, PhD
QuintilesIMS health
Data Analyst/Consultant

Nils went to medical school in Gothenburg and worked as a clinician for three years. He then went on to complete his PhD in Pharmacoepidemiology at the University of Gothenburg. From there he was a Postdoc at Center for Pharmacoepidemiology for 1 year before joining QuintilesIMS in 2016 as a project manager in observational research projects, primarily with pharmaceutical companies as clients.

Ana Catarina Araújo Silva, PhD

Calmark Sweden
Product Developer

Ana Catarina Araújo Silva is from Lisbon, Portugal, and has been living in Stockholm since 2009. She has a background within materials and medicinal chemistry with a European PhD in Organic Chemistry from University of Lisbon and University of Milano-Bicocca in Italy. After the PhD, Ana Catarina held postdoctoral fellowship positions in bioorganic and physical chemistry to broaden her knowledge in other fields than drug development.
The last postdoctoral fellowship in biochemistry, a project on development of paper-based DNA diagnostic tests, in the end served as a bridge to her current position. In 2015, Ana Catarina took a position as a product developer at a MedTech startup company developing point-of-care devices to measure biomarkers for neonatal care. Since then she has taken a leading role in conceptual design and product development. The academic background has given her valuable experience in problem solving, laboratory experimental design and method development.

Anna Omelyanenko, PhD

Boston Consulting Group
Associate

Anna completed her PhD in 2016 at Karolinska Institutet in the Department of Medical Biochemistry and Biophysics, Division of Molecular Neurobiology/Department of Physiology and Pharmacology, Division of Pharmacology working on basic biology of mouse embryonic and neural stem cells. Prior to defending her thesis, Anna was recruited as a business analyst at QuintilesIMS after an internship at the company during participation in the National Research School in Drug Discovery and Development held by KI in 2015. Anna moved to the Boston Consulting Group as an Associate in early 2017.

Barbara Albiger, PhD
European Centre for Disease Prevention and Control (ECDC)
Expert in Microbiology, Microbiology Coordination Section, Office of the Chief Scientist


Barbara obtained her PhD degree in molecular and cellular biology in 1998 from the University of Strasbourg, France, and then in 2008 became Associate Professor in medical microbiology at Lund University, Sweden. Before joining ECDC in 2011, she worked at the Karolinska Institute and the Swedish Public Health Institute (1998 ̶ 2006) and at Lund University (2006 ̶ 2011), where she coordinated research projects on the role of innate immunity in protection against bacterial infections.

At ECDC, she was the Programme Manager and the Deputy Head of the Programme, Antimicrobial Resistance & Healthcare-Associated Infections from 2011 to 2015. In 2016, she joined the Microbiology Coordination Section to support ECDC mandate of fostering sufficient capacity within the European Union for the diagnosis, detection, identification and characterisation of infectious agents which may threaten public health. Since 2017, she joined the Scientific Advice Coordination Section to promote ECDC scientific excellence and leadership to become a major resource for scientific information and advice on infectious diseases for the Member States and their citizens.

Ann Lundström, PhD
Naturvetarna
Career Advisor


"Today I work as a Career advisor at Naturvetarna, the Swedish Association of Professional Scientists, a position I have had since 2011. I coach our members (personal counselling, CV, LinkedIn, Career profile analysis, Personal Profile Analysis) have workshops and seminars and are involved in different projects such as making an opinion in research politics, marketing scientific competence and so on.
25 % of Naturvetarna’s members have a Ph D and I got the job as a Career advisor because of my experience from both academia and industry. 2004 I got my Ph D in Molecular genetics at SU (title of my thesis was ”Function and regulation of release factor one in Escherichia coli”). After my disputation I started as a postdoc at MTC/KI in Mikael Rehns group looking at virulence factors in Salmonella. I did my work both at MTC and in Norwich/UK (Jay Hinton’s lab). Being hired for 1-2 months at a time I had to apply for other positions and after 9 months I took the decision to leave academia and start as a sales rep in Life Science. I worked as a Product specialist at BioNordika a Product Manager at Nordic BioSite, and an Account manager at Roche Diagnostics for a total of 6 years (in between 2005-2011)."

Magnus Nord, PhD
AstraZeneca
Director and Head of the Translational Science Centre

Magnus completed his PhD in Cellular and Molecular Biology in 1997 at Karolinska Institutet before taking up a position as a research scientist and study director at Karolinska Institutet until 2002. In 2003 Magnus became an Associate Professor at Karolinska Institutet and a respiratory physician at Karolinska University Hospital. He moved to AstraZeneca R&D in 2006 as a Senior Research Scientists. Magnus is currently Vice President of Global Patient Safety for Cardiovascular and Metabolic diseases for AstraZeneca as well as a Professor at Karolinska Institutet investigating signalling mechanisms and drug transporters in inflammatory lung diseases.

Bernadette Schriener, PhD
Olerup SSP
Molecular Biologist

Bernadette completed her PhD in Biochemistry in the laboratory of Prof. Walter Neupert at Munich University, Germany studying import pathways and folding of proteins in mitochondria in S. cerevisiae. Subsequently, she acquired a postdoctoral fellowship of the German Research Foundation and joined the laboratory of Associate Professor Maria Ankarcrona at the Center for Alzheimer Research at Karolinska Institutet in Stockholm, Sweden where she investigated mitochondrial function and dysfunction in the context of Alzheimer’s disease in cell and mouse models.
Since June 2016, she has been working as a Molecular Biologist at Olerup/CareDx, a global Biotech Company based in Stockholm dedicated to developing and improving methods for HLA genotyping. Bernadette is responsible for the entire development pipeline from reaction design, testing and analysis to quality control as well as writing study plans, reports and standard operating procedures.

Per Lundin, PhD
Evox Therapeutics
Chief Operating Officer

Per completed undergraduate and masters studies in Business Administration and Economics and holds a Licentiate in Neurochemistry. Per completed his PhD in the Unit for Molecular Cell Biology and Gene Therapy Science in the Department of Medicine, Karolinska Institutet in 2011. He was then recruited by Thompson Reuters as a Business Development Manager and later as a European Law Firm Market Manager. While at Thompson Reuters, Per became CEO of IsletOne Therapeutics, a regenerative medicine company focused on cell therapies in cardiology and inflammation/autoimmunity. At present Per is the Chief Operating Officer of Evox Therapeutics and a non-executive director of IsletOne Therapeutics.

Samir El Andaloussi, PhD
Evox Therapeutics
Group Leader

Samir completed his PhD in Neurochemistry at Stockholm University in 2008. He then went on to complete three postdocs, one in his PhD lab in collaboration with University of Tartu, Finland, one in the Department of Laboratory Medicine, Karolinska Institutet, and the other in the Department of Physiology, Anatomy and Genetics, University of Oxford. Samir returned to Sweden as an Assistant Professor in the Department of Laboratory Medicine at Karolinska Institutet in 2013. In 2016, he founded Evox Therapeutics using a 120MSEK seed fund.

Anders Mälarstig, PhD
Pfizer
Director

Anders’ PhD was undertaken in the Department of Medical Sciences, Uppsala University and focussed on understanding inter-individual differences in inflammation response and coagulation activation. After defending his thesis in 2006 Anders undertook a postdoc at Karolinska Institutet aimed at mapping new risk genes for cardiovascular disease and its risk factors.

From 2011 Per held joint appointment as a Senior Research Associate in the Department of Public Health, Cambridge University, United Kingdom and as Manager of Sandwich human genetics group, Molecular Medicine, Clinical Research, Pfizer, United Kingdom. In 2013 Per became the Director of Human Genetics, Genome Sciences and Technologies, Pfizer Worldwide Research and Development, Stockholm, Sweden, a position he holds in addition to being a Research Associate in the Department of Medicine at Karolinska Institute and Head of UK CVD Genetics for Pfizer Neusentis.

Hovsep Mahdessiam, PhD
Bayer
Medical Science Laison

After completing a Masters in Engineering in Biotechnology from KTH in 2009, Hovsep moved to KI to pursue a PhD within Cardiovascular Diseases. He defended his thesis in 2014 and went on to complete two years as a Postdoc at Karolinska Institutet. In parallel with his studies, he was involved in establishing a clothing brand in Sweden with three physical stores in Stockholm.

In 2016, Hovsep decided to pursue a career outside academia and joined Miltenyi Biotec as a Regional Account Manager in Sweden. In January 2017, he joined the Medical Affairs team at Bayer in Scandinavia as a Medical Scientific Liaison for Sweden within the Cardiovascular Diseases area. Hovsep remains affiliated with KI and collaborates with his former research groups on a voluntary basis with six publications in pipeline.

Mira Ernkvist, PhD
Roche
Country Medical Lead


Mira undertook her PhD at Department of Oncology and Pathology in Cancer Centrum Karolinska between 2003 to 2008. After defending her thesis on angiogenesis she became a product specialist at Roche. From 2011 – 2014, she worked as product manager within several different oncology indications (melanoma, breast cancer, lung cancer) and as Country Medical Manager for lung cancer between 2014 to 2016. Presently Mira is Country Medical Lead within the fields of lung cancer, lung diseases and immune-oncology.